Univ.-Prof. Dr. Gerald Gartlehner, MPH

Akl, E.A.; Morgan, R.L.; Rooney, A.A.; Beverly, B.; Katikireddi, S.V.; Agarwal, A.; Alper, B.S.; Alva-Diaz, C.; Amato, L.; Ansari, M.T.; Brozek, J.; Chu, D.K.; Dahm, P.; Darzi, A.J.; Falavigna, M.; Gartlehner, G.; Pardo-Hernandez, H.; King, V.; Klugarova, J.; Langendam, M.W.M.; Lockwood, C. (2021). Developing trustworthy recommendations as part of an urgent response (1e2 weeks): a GRADE concept paper. Journal of Clinical Epidemiology, 129: 1-11

Dobrescu, A.; Nussbaumer-Streit, B.; Klerings, I.; Wagner, G.; Persad, E.; Sommer, I.; Herkner, H.; Gartlehner, G. (2021). Restricting evidence syntheses of interventions to English-language publications is a viable methodological shortcut for most medical topics: a systematic review. Journal of Clinical Epidemiology, 137: 209-217

Garritty, C.; Gartlehner, G.; Nussbaumer-Streit, B.; King, V.J.; Hamel, C.; Kamel, C.; Affengruber, L.; Stevens, A. (2021). Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. Journal of Clinical Epidemiology, 130: 13-22

Gartlehner, G.; Crotty, K.; Kennedy, S.; Edlund, M.J.; Ali, R.; Siddiqui, M.; Fortman, R.; Wines, R.; Persad, E.; Viswanathan, M. (2021). Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis. CNS Drugs, https://doi.org/10.1007/s40263-021-00855-4: https://doi.org/10.1007/s40263-021-00855-4

Noel-Storr, A.; Dooley, G.; Affengruber, L.; Gartlehner, G. (2021). Citation screening using crowdsourcing and machine learning produced accurate results: Evaluation of Cochrane’s modified Screen4Me service. Journal of Clinical Epidemiology, 130: 23-31

Nußbaumer-Streit, B.; Ellen, M.; Klerings, I.; Sfetcu, R.; Riva, N.; Mahmic-Kaknjo, M.; Poulentzas, G.; Martinez, P.; Baladia, E.; Ziganshina, L.E.; Marques, M.E.; Aguilar, L.; Kassianos, A.P.; Frampton, G.; Silva, A.G.; Affengruber, L.; Spjker, R.; Thomas, J.; Berg, R.C.; Kontogiani, M.; Sousa, M.; Kontogiorgis, C.; Gartlehner, G.; (2021). Resource use during systematic review production varies widely: a scoping review. Journal of Clinical Epidemiology, In Press, Corrected Proof: https://doi.org/10.1016/j.jclinepi.2021.05.019

Nußbaumer-Streit, B.; Thaler, K.; Chapman, A.; Probst, T.; Winkler, D.; Sönnichsen, A.; Gaynes, B.N.; Gartlehner, G. (2021). Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD008591.: 1465-1858

Sommer, I.; Nussbaumer-Streit, B.; Gartlehner, G. (2021). WHO-Leitlinie: Körperliche Aktivität, Bewegungsmangel und Schlaf für Kinder unter 5 Jahren. Gesundheitswesen, efirst: 10.1055/a-1489-8049

Sommer, I.; Titscher, V.; Szelag, M.; Gartlehner, G. (2021). What are the Relevant Outcomes of the Periodic Health Examination? A Comparison of Citizens' and Experts' Ratings. Patient Prefer Adherence, 15: 57-68

Stamm, T.A.; Andrews, M.R.; Mosor, E.; Ritschl, V.; Li, L.C.;; Ma, J.K.; Campo-Arias, A.; Baker, S.; Burton, N.W. Eghbali, M.; Fernandez, N.; Ferreira, R.J.O.; Gäbler, G.; Makri, S.; Mintz, S.; Moe, R.H.; Morasso, E.; Murphy, S.L.; Ntuli, S.; Omara, M.; Simancas-Pallares, M.A.; Horonieff, J.; Gartlehner, G. (2021). The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic review. Journal of Clinical Epidemiology, 135: 125-135

Van den Nest, M.; Wagner, G.; Riesenhuber, M.; Dolle, C.; Presterl, E.; Gartlehner, G.; Moertl, D.; Willinger, B. (2021). Filamentous Fungal Infections in a Tertiary Care Setting: Epidemiology and Clinical Outcome. Journal of Fungi, 7: 40

Wagner, G.; Moertl, D.; Glechner, A.; Mayr, V.; Klerings, I.; Zachariah, C.; Van den Nest, M.; Gartlehner, G.; Willinger, B. (2021). Paracoccidioidomycosis Diagnosed in Europe—A Systematic Literature Review. Journal of Fungi, 7(2), 157: https://doi.org/10.3390/jof7020157

Glechner, A.; Stratil, J.M.; Bombana, M.; Griebler, U.; Zeeb, H.; Gartlehner, G. (2021). COVID-19-Pandemie: Sind harte Lockdowns unwirksam? Warum die Studie von Bendavid et al. dafür kein Beweis ist. Zeitschrift für Allgemeinmedizin, 97 (3): 103-107, Deutscher Ärzteverlag

Glechner, A.; Stratil, J.M.; Bombana, M.; Griebler, U.; Zeeb, H.; Gartlehner, G. (2021). COVID-19-Pandemie: Sind harte Lockdowns unwirksam? Warum die Studie von Bendavid et al. dafür kein Beweis ist. Zeitschrift für Allgemeinmedizin, 97 (3): 103-107, Deutscher Ärzteverlag

Affengruber, L.; Wagner, G.; Waffenschmidt, S.; Lhachimi S.K.; Nussbaumer-Streit, B.; Thaler, K.; Griebler, U.; Klerings, I.; Gartlehner, G. (2020). Combining abbreviated literature searches with single-reviewer screening: three case studies of rapid reviews. Systematic Reviews, 9(1):162.: doi:10.1186/s13643-020-01413-7

Chevance, A.; Ravaud, P.; Tomlinson, A.; Le Berre C.; Teufer, B.; Touboul, S.; Fried, E.I.; Gartlehner, G.; Cipriani, A.; Thi Tran, V.; (2020). Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international online survey. The Lancet Psychiatry, Volume 7, Issue 8: 692-702

Christof, C.; Nußbaumer-Streit, B.; Gartlehner, G. (2020). WHO-Leitlinie: Prävention und Kontrolle von Tuberkulose-Infektionen. Das Gesundheitswesen, online publiziert 2020: DOI: 10.1055/a-1241-4321

Ewald, H., Klerings, I.; Wagner, G.; Heise, T.L.; Dobrescu, A.I.; Armijo-Olivo, S.; Stratil, J.M.; Lhachimi, S.K.; Mittermayr, T.; Gartlehner, G.; Nussbaumer-Streit, B.; Hemkens, L.G. (2020). Abbreviated and comprehensive literature searches led to identical or very similar effect estimates: a meta-epidemiological study. Journal of Clinical Epidemiology, 128: 1-12

Garritty, C.;Gartlehner, G.; Nussbaumer-Streit, B.;King, V.J.; Kamel, C.; Stevens, A.; Devane, D.; Hamel, C.; Affengruber, L. (2020). Rapid review methods guidance aids in Cochrane’s quick response to the COVID-19 crisis. Cochrane Database of Systematic Reviews, (12 Suppl 1): 28-29

Gartlehner, G.; Affengruber, L.; Titscher, V.; Noel-Storr, A.; Dooley, G.; Ballarini, N.; König, F. (2020). Single-reviewer abstract screening missed 13 percent of relevant studies:a crowd-based, randomized controlled trial. Journal of Clinical Epidemiology, 121: 20-28